Psychiatry and Neurology, Neurology · Chattanooga, TN
NPI
1851349989
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
979 E 3rd St, Suite B-1210
Chattanooga, TN, 37403
Phone (423) 778-4261
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
353 services
Medicare patients, 2024
202
Average age 71
Drug cost, 2024
$611K
1,775 prescriptions
Company payments, 2025
$5,578
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Rankine was code 99214 (office e&m - established), 83 times for 73 patients. In total David A Rankine billed 353 services in 16 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 83 | 73 | $74.63 | $6,194 |
| 99215 Office E&M - Established | Facility | 54 | 48 | $108.35 | $5,851 |
| 99214 Office E&M - Established | Office | 38 | 29 | $134.74 | $5,120 |
| 95886 Electrical Nerve Conductivity | Office | 36 | 21 | $97.73 | $3,518 |
| 99205 Office E&M - New | Office | 26 | 26 | $218.71 | $5,686 |
| 99215 Office E&M - Established | Office | 24 | 21 | $195.51 | $4,692 |
| 99205 Office E&M - New | Facility | 17 | 17 | $129.54 | $2,202 |
By year: 2022 $45K for 436 services; 2023 $53K for 498 services; 2024 $42K for 353 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A Rankine prescribed most often to Medicare patients was Gabapentin, with 231 prescriptions and refills. In total David A Rankine wrote 1,775 Medicare prescriptions that cost $611K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 231 | 330 | 56 | $5,747 |
| Donepezil Hcl Generic | 215 | 356 | 63 | $2,253 |
| Rasagiline Mesylate Generic | 125 | 271 | 31 | $20K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 99 | 184 | 29 | $5,054 |
| Pentoxifylline Generic | 64 | 104 | 15 | $1,826 |
| Memantine Hcl Generic | 54 | 93 | 17 | $804 |
| Zonisamide Generic | 51 | 67 | 13 | $1,025 |
| Primidone Generic | 47 | 75 | 12 | $662 |
| Divalproex Sodium Er Divalproex Sodium | 45 | 47 | Under 11 | $628 |
| Sertraline Hcl Generic | 42 | 66 | Under 11 | $217 |
| Pregabalin Generic | 37 | 49 | Under 11 | $1,587 |
| Briviact Brivaracetam | 36 | 40 | Under 11 | $51K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 32 | 44 | Under 11 | $1,103 |
| Lamotrigine Generic | 30 | 59 | Under 11 | $470 |
| Entacapone Generic | 29 | 35 | Under 11 | $2,436 |
Brand drugs: 201 claims; generic drugs: 1,574 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Rankine $5,578 ($5,578 in general payments such as food, travel and fees) from 4 companies. The largest payer was UCB, Inc. with $3,050.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.